Tradition Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-313
Closed -$54K 1124
2022
Q1
$54K Sell
313
-22
-7% -$3.7K 0.01% 499
2021
Q4
$85K Buy
+335
New +$97.9K 0.01% 431
2021
Q3
Sell
-100
Closed -$23K 1190
2021
Q2
$23K Sell
100
-10
-9% -$1.79K ﹤0.01% 727
2021
Q1
$14K Buy
110
+10
+10% +$1.45K ﹤0.01% 709
2020
Q4
$10K Buy
+100
New +$10.1K ﹤0.01% 744

Other funds holding MRNA

Tradition Wealth Management's MRNA Position: Q2 2022 in Review

Tradition Wealth Management sold out of Moderna (MRNA) in Q2 2022, closing a stake of 313 shares — an estimated $54K sold.

Tradition Wealth Management first reported a position in MRNA in Q4 2020 and held it in 5 quarters. The position peaked at $85K in Q4 2021. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Tradition Wealth Management reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
  • Tradition Wealth Management sold 313 Moderna shares in Q2 2022, an estimated $54K.
  • Tradition Wealth Management first reported a position in Moderna in Q4 2020 and held it in 5 quarters.
  • Tradition Wealth Management's Moderna position peaked at $85K in Q4 2021.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Tradition Wealth Management's 13F filing for Q2 2022, filed 2 Aug 2022.